These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1162178)

  • 1. Comparison of 3,4-dimethoxyphenylethylamine treated plasma from chronic schizophrenics and controls.
    Bergen JR; Mulhall S; Moorman P
    Res Commun Chem Pathol Pharmacol; 1975 Feb; 10(2):331-5. PubMed ID: 1162178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projection of an endocoid involved with schizophrenic reaction.
    Proctor CD; Cho JB; Nicolls AA
    Prog Clin Biol Res; 1985; 192():387-93. PubMed ID: 4080716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An influence of blood plasma from schizophrenics on an action of 3,4-dimethoxyphenylethylamine.
    Proctor CD; Cho JB; Potts JL; Ashley LG; Douglas JG; Amoroso CP; McGriff JE; Eaton HE
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):95-105. PubMed ID: 5650338
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors affecting an influence of blood plasma from schizophrenics on an action of 3,4-dimethoxyphenylethylamine.
    Proctor CD; Cho JB; Ashley LG; Potts JL; Eaton HE; McGriff JE; Douglas JG; Amoroso CP
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):106-21. PubMed ID: 5650321
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of blood serum or plasma from schizophrenic patients and others on an action of 3,4-dimethoxyphenylethylamine: a failure to replicate.
    Meltzer HY; Boyer M
    Arch Int Pharmacodyn Ther; 1969 Dec; 182(2):481-8. PubMed ID: 5371207
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 7. Failure of plasma from schizophrenics to potentiate the effects of 3,4-dimethoxyphenylethylamine on rats and mice.
    Masur J; Breda JB; Bueno OF; Carlini EA
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):56-64. PubMed ID: 5348399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Psychomimetic compounds in the urine of schizophrenics. I. Study of catechol derivatives: so-called Pink Spot and 3.4-dimethoxyphenylethylamine (DMPEA)].
    Willmann PK; Bidziński A; Jakimow B; Puzyński S
    Psychiatr Pol; 1977; 11(2):143-9. PubMed ID: 887672
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine oxidase inhibitors potentiate phenylethylamine effects in rhesus monkeys.
    Staub RA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1980 Jun; 15(3):429-36. PubMed ID: 6769508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Toxicity of a dimethoxyphenylethylamine incubate with the blood plasma of schizophrenia patients].
    Morozov LT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(3):396-8. PubMed ID: 4466274
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative investigation on the urinary excretion and metabolism of 3,4-dimethoxyphenylethylamine in schizophrenics and normal individuals.
    Hempel K; Ullrich H; Philippu G
    Biol Psychiatry; 1982 Jan; 17(1):49-59. PubMed ID: 7059639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses.
    Heikkila RE; Cabbat FS; Manzino L; Babington RG; Houlihan WJ
    J Pharmacol Exp Ther; 1981 Jun; 217(3):745-9. PubMed ID: 7194909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychoactivity of normacromerine in animals.
    Bourn WM; Keller WJ; Bonfiglio JF
    Life Sci; 1978 Sep; 23(11):1175-84. PubMed ID: 713693
    [No Abstract]   [Full Text] [Related]  

  • 14. Responses of developing rats to L-tryptophan plus an maoi-II. Effects of repeated electroconvulsive shock.
    Atterwill CK; Green AR
    Neuropharmacology; 1980 Apr; 19(4):337-41. PubMed ID: 7189832
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine sensitization in rats as an animal model of schizophrenia.
    Peleg-Raibstein D; Knuesel I; Feldon J
    Behav Brain Res; 2008 Aug; 191(2):190-201. PubMed ID: 18486243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Excretion of 3,4-dimethoxy phenylethylamine in the urine of schizophrenics].
    Zimmermann K; Moschke P; Wieder KH
    Psychiatr Neurol Med Psychol (Leipz); 1976 Mar; 28(3):163-73. PubMed ID: 967948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the central effects of 5,6-dihydroxytryptamine.
    Longo VG; Scotti de Carolis A; Liuzzi A; Massotti M
    Adv Biochem Psychopharmacol; 1974; 10():109-20. PubMed ID: 4546514
    [No Abstract]   [Full Text] [Related]  

  • 18. Central action of drugs acting on the cholinergic muscarinic receptor. III. Influence of atropine and scopolamine injected intraventricularly on behavior and levels of biogenic amines in the rat brain.
    Zebrowska-Lupina I; Kleinrok Z; Poddubiuk Z
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):485-95. PubMed ID: 1172421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of beta-phenylethylamine on locomotor activity and brain catecholamine metabolism in mice].
    Motohashi N; Nakagawara M; Semba J; Ishii K; Watanabe A; Kariya T
    Yakubutsu Seishin Kodo; 1983 Sep; 3(2):67-75. PubMed ID: 6659713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.